02161.HK
JBM (Healthcare) Limited
HKSE · Healthcare · Drug Manufacturers - Specialty & Generic · HK
HKD 1.89
+1.61%Jul 20, 2026, 01:34 UTC
JBM Healthcare (02161.HK) announced a proposed spin-off of its branded Chinese patent medicine and Chinese medicine clinic services business, including Po Chai Pills, for a separate listing on the Main Board of the Stock Exchange of Hong Kong via a global offering of Po Chai Yuan shares.
Source:Jun 22, 2026, 15:59 UTC
JBM (Healthcare) Limited recommended a final dividend of HK7.35 cents per share.
Source:Jun 22, 2026, 15:59 UTC
JBM (Healthcare) Limited announced its FY2026 annual results, reporting revenue growth of 6.7% and a 1.9% increase in profit attributable to shareholders.
Source: